vs
Acadia Healthcare Company, Inc.（ACHC）与VEEVA SYSTEMS INC（VEEV）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是VEEVA SYSTEMS INC的1.0倍（$821.5M vs $811.2M），VEEVA SYSTEMS INC净利率更高（29.1% vs -143.3%，领先172.5%），VEEVA SYSTEMS INC同比增速更快（16.0% vs 6.1%），过去两年VEEVA SYSTEMS INC的营收复合增速更高（13.4% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Veeva Systems Inc总部位于美国加利福尼亚州普莱森顿，是一家公益类上市企业，专注为生命科学行业提供云软件、数据服务及商业咨询，旗下产品可实现数据管理、监管注册跟踪、供应链全流程监督等多项功能。
ACHC vs VEEV — 直观对比
营收规模更大
ACHC
是对方的1.0倍
$811.2M
营收增速更快
VEEV
高出9.9%
6.1%
净利率更高
VEEV
高出172.5%
-143.3%
两年增速更快
VEEV
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $811.2M |
| 净利润 | $-1.2B | $236.2M |
| 毛利率 | — | 75.4% |
| 营业利润率 | -142.4% | 29.7% |
| 净利率 | -143.3% | 29.1% |
| 营收同比 | 6.1% | 16.0% |
| 净利润同比 | -3710.4% | 27.1% |
| 每股收益（稀释后） | $-12.98 | $1.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCVEEV
| Q4 25 | $821.5M | $811.2M | ||
| Q3 25 | $851.6M | $789.1M | ||
| Q2 25 | $869.2M | $759.0M | ||
| Q1 25 | $770.5M | $720.9M | ||
| Q4 24 | $774.2M | $699.2M | ||
| Q3 24 | $815.6M | $676.2M | ||
| Q2 24 | $796.0M | $650.3M | ||
| Q1 24 | $768.1M | $630.6M |
净利润ACHCVEEV
| Q4 25 | $-1.2B | $236.2M | ||
| Q3 25 | $36.2M | $200.3M | ||
| Q2 25 | $30.1M | $228.2M | ||
| Q1 25 | $8.4M | $195.6M | ||
| Q4 24 | $32.6M | $185.8M | ||
| Q3 24 | $68.1M | $171.0M | ||
| Q2 24 | $78.5M | $161.7M | ||
| Q1 24 | $76.4M | $147.4M |
毛利率ACHCVEEV
| Q4 25 | — | 75.4% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 77.1% | ||
| Q1 25 | — | 74.9% | ||
| Q4 24 | — | 75.1% | ||
| Q3 24 | — | 74.8% | ||
| Q2 24 | — | 73.3% | ||
| Q1 24 | — | 72.4% |
营业利润率ACHCVEEV
| Q4 25 | -142.4% | 29.7% | ||
| Q3 25 | 4.7% | 24.8% | ||
| Q2 25 | 5.8% | 30.8% | ||
| Q1 25 | 1.7% | 26.1% | ||
| Q4 24 | 4.9% | 25.9% | ||
| Q3 24 | 12.1% | 24.6% | ||
| Q2 24 | 13.4% | 23.9% | ||
| Q1 24 | 12.9% | 21.4% |
净利率ACHCVEEV
| Q4 25 | -143.3% | 29.1% | ||
| Q3 25 | 4.3% | 25.4% | ||
| Q2 25 | 3.5% | 30.1% | ||
| Q1 25 | 1.1% | 27.1% | ||
| Q4 24 | 4.2% | 26.6% | ||
| Q3 24 | 8.4% | 25.3% | ||
| Q2 24 | 9.9% | 24.9% | ||
| Q1 24 | 9.9% | 23.4% |
每股收益（稀释后）ACHCVEEV
| Q4 25 | $-12.98 | $1.40 | ||
| Q3 25 | $0.40 | $1.19 | ||
| Q2 25 | $0.33 | $1.37 | ||
| Q1 25 | $0.09 | $1.17 | ||
| Q4 24 | $0.36 | $1.13 | ||
| Q3 24 | $0.74 | $1.04 | ||
| Q2 24 | $0.85 | $0.98 | ||
| Q1 24 | $0.83 | $0.90 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $1.7B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $7.0B |
| 总资产 | $5.5B | $8.1B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCVEEV
| Q4 25 | $133.2M | $1.7B | ||
| Q3 25 | $118.7M | $1.9B | ||
| Q2 25 | $131.4M | $2.0B | ||
| Q1 25 | $91.2M | $1.1B | ||
| Q4 24 | $76.3M | $1.0B | ||
| Q3 24 | $82.1M | $1.2B | ||
| Q2 24 | $77.2M | $1.2B | ||
| Q1 24 | $77.3M | $703.5M |
总债务ACHCVEEV
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCVEEV
| Q4 25 | $1.9B | $7.0B | ||
| Q3 25 | $3.1B | $6.6B | ||
| Q2 25 | $3.1B | $6.2B | ||
| Q1 25 | $3.0B | $5.8B | ||
| Q4 24 | $3.1B | $5.5B | ||
| Q3 24 | $3.0B | $5.2B | ||
| Q2 24 | $3.0B | $4.9B | ||
| Q1 24 | $2.9B | $4.6B |
总资产ACHCVEEV
| Q4 25 | $5.5B | $8.1B | ||
| Q3 25 | $6.4B | $8.0B | ||
| Q2 25 | $6.3B | $7.8B | ||
| Q1 25 | $6.1B | $7.3B | ||
| Q4 24 | $6.0B | $6.5B | ||
| Q3 24 | $5.9B | $6.3B | ||
| Q2 24 | $5.7B | $6.2B | ||
| Q1 24 | $5.5B | $5.9B |
负债/权益比ACHCVEEV
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $192.8M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | — |
| 自由现金流率自由现金流/营收 | -21.8% | — |
| 资本支出强度资本支出/营收 | 11.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.82× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | — |
8季度趋势，按日历期对齐
经营现金流ACHCVEEV
| Q4 25 | $-86.3M | $192.8M | ||
| Q3 25 | $73.2M | $238.4M | ||
| Q2 25 | $133.5M | $877.2M | ||
| Q1 25 | $11.5M | $69.5M | ||
| Q4 24 | $116.7M | $164.1M | ||
| Q3 24 | $163.1M | $92.9M | ||
| Q2 24 | $171.1M | $763.5M | ||
| Q1 24 | $-321.3M | $57.8M |
自由现金流ACHCVEEV
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | — |
自由现金流率ACHCVEEV
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | — |
资本支出强度ACHCVEEV
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 18.5% | — |
现金转化率ACHCVEEV
| Q4 25 | — | 0.82× | ||
| Q3 25 | 2.02× | 1.19× | ||
| Q2 25 | 4.43× | 3.84× | ||
| Q1 25 | 1.37× | 0.36× | ||
| Q4 24 | 3.58× | 0.88× | ||
| Q3 24 | 2.39× | 0.54× | ||
| Q2 24 | 2.18× | 4.72× | ||
| Q1 24 | -4.21× | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
VEEV
| Subscription Services Veeva Research And Development | $364.8M | 45% |
| Subscription Services Veeva Commercial Cloud | $317.6M | 39% |
| Professional Services Veeva Research And Development | $81.3M | 10% |
| Professional Services Veeva Commercial Cloud | $47.5M | 6% |
